Megan E. Luedeman

Megan E. Luedeman

Auto-generated profile, based on publicly available information

Megan E. Luedeman

Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2018 in Science
Verified
Journal Article
Closed access
PDF file
JPJohn M. Pryor
John M. Pryor
MCMichael P. Conlin
Michael P. Conlin
JCJuan Carvajal-Garcia
Juan Carvajal-Garcia
MLMegan E. Luedeman
Megan E. Luedeman
ALAdam J. Luthman
Adam J. Luthman
DRDale A. Ramsden
Dale A. Ramsden
RNA takes over DNA repair: Damage to DNA genomes is normally thought to be repaired with DNA. Pryor et al. now describe a clear exception (see the Perspective by Modesti). They found that RNA is routinely incorporated during the repair of DNA double-strand breaks through the mammalian nonhomologous end–joining (NHEJ) pathway. In a variety of contexts, including V(D)J recombination and Cas9-induced genome engineering, two “DNA” polymerases specific to NHEJ preferentially added RNA in cells. These RNA additions facilitated the critical step of ligation and were later replaced by DNA to complete the NHEJ repair process. Science , this issue p. 1126 ; see also p. 1069

4 August 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
MLMegan E. Luedeman
Megan E. Luedeman
SSSusanna Stroik
Susanna Stroik
WFWanjuan Feng
Wanjuan Feng
ALAdam J. Luthman
Adam J. Luthman
GGGaorav P. Gupta
Gaorav P. Gupta
DRDale A. Ramsden
Dale A. Ramsden
The DNA polymerase theta (Polθ)-mediated end joining (TMEJ) pathway for repair of chromosomal double strand breaks (DSBs) is essential in cells deficient in other DSB repair pathways, including hereditary breast cancers defective in homologous recombination. Strand-break activated poly(ADP) ribose polymerase 1 (PARP1) has been implicated in TMEJ, but the modest specificity of existing TMEJ assays means the extent of effect and the mechanism behind it remain unclear. We describe here a series of TMEJ assays with improved specificity and show ablation of PARP activity reduces TMEJ activity 2-4-fold. The reduction in TMEJ is attributable to a reduction in the 5’ to 3’ resection of DSB ends that is essential for engagement of this pathway and is compensated by increased repair by the nonhomologous-end joining pathway. This limited role for PARP activity in TMEJ helps better rationalize the combined employment of inhibitors of PARP and Polθ in cancer therapy.

4 February 2022 in Research Square
Verified
Preprint
Open access
PDF file
MLMegan Luedeman
Megan Luedeman
SSSusanna Stroik
Susanna Stroik
WFWanjuan Feng
Wanjuan Feng
ALAdam Luthman
Adam Luthman
GGGaorav Gupta
Gaorav Gupta
DRDale Ramsden
Dale Ramsden
The DNA polymerase theta (Polθ)-dependent end joining (TMEJ) pathway for repair of chromosomal double strand breaks (DSBs) is essential in cells deficient in other DSB repair pathways, including hereditary breast cancers defective in homologous recombination. Strand-break activated poly(ADP) ribose polymerase 1 (PARP1) has been implicated in TMEJ, but the modest specificity of existing TMEJ assays means the extent of effect and the mechanism behind it remain unclear. We describe here a series of TMEJ assays with improved specificity and show ablation of PARP activity reduces TMEJ activity 2-4-fold. The reduction in TMEJ is attributable to a reduction in the 5’ to 3’ resection of DSB ends that is essential for engagement of this pathway and is compensated by increased repair by the nonhomologous-end joining pathway. This limited role for PARP activity in TMEJ helps better rationalize the combined employment of inhibitors of PARP and Polθ in cancer therapy.